Cargando…

Minimal ablative margin (MAM) assessment with image fusion: an independent predictor for local tumor progression in hepatocellular carcinoma after stereotactic radiofrequency ablation

OBJECTIVES: To assess the minimal ablative margin (MAM) by image fusion of intraprocedural pre- and post-ablation contrast-enhanced CT images and to evaluate if it can predict local tumor progression (LTP) independently. Furthermore, to determine a MAM with which a stereotactic radiofrequency ablati...

Descripción completa

Detalles Bibliográficos
Autores principales: Laimer, Gregor, Schullian, Peter, Jaschke, Nikolai, Putzer, Daniel, Eberle, Gernot, Alzaga, Amilcar, Odisio, Bruno, Bale, Reto
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7160081/
https://www.ncbi.nlm.nih.gov/pubmed/32002642
http://dx.doi.org/10.1007/s00330-019-06609-7
_version_ 1783522686568235008
author Laimer, Gregor
Schullian, Peter
Jaschke, Nikolai
Putzer, Daniel
Eberle, Gernot
Alzaga, Amilcar
Odisio, Bruno
Bale, Reto
author_facet Laimer, Gregor
Schullian, Peter
Jaschke, Nikolai
Putzer, Daniel
Eberle, Gernot
Alzaga, Amilcar
Odisio, Bruno
Bale, Reto
author_sort Laimer, Gregor
collection PubMed
description OBJECTIVES: To assess the minimal ablative margin (MAM) by image fusion of intraprocedural pre- and post-ablation contrast-enhanced CT images and to evaluate if it can predict local tumor progression (LTP) independently. Furthermore, to determine a MAM with which a stereotactic radiofrequency ablation (SRFA) can be determined successful and therefore used as an intraprocedural tool to evaluate treatment success. METHODS: A total of 110 patients (20 women, 90 men; mean age 63.7 ± 10.2) with 176 hepatocellular carcinomas were assessed by retrospective analysis of prospectively collected data. The MAM was determined through image fusion of intraprocedural pre- and post-ablation images using commercially available rigid imaging registration software. LTP was assessed in contrast-enhanced CTs or MR scans at 3–6-month intervals. RESULTS: The MAM was the only significant independent predictor of LTP (p = 0.036). For each millimeter increase of the MAM, a 30% reduction of the relative risk for LTP was found (OR = 0.7, 95% CI 0.5–0.98, p = 0.036). No LTP was detected in lesions with a MAM > 5 mm. The overall LTP rate was 9 of 110 (8.2%) on a patient level and 10 of 173 (5.7%) on a lesion level. The median MAM was 3.4 (1.7–6.9) mm. The mean overall follow-up period was 26.0 ± 10.3 months. CONCLUSIONS: An immediate assessment of the minimal ablative margin (MAM) can be used as an intraprocedural tool to evaluate the treatment success in patients treated with stereotactic RFA. A MAM > 5 mm has to be achieved to consider an ablation as successful. KEY POINTS: • An intraoperatively measured minimal ablative margin (MAM) > 5 mm correlates with complete remission. • MAM is the only significant independent predictor of LTP (OR = 0.7, 95% CI 0.5–0.98, p = 0.036) after stereotactic RFA of hepatocellular carcinoma. • Image fusion using commercially available rigid imaging registration software is possible, even though considerably complex. Therefore, improved (semi-)automatic fusion software is highly desirable.
format Online
Article
Text
id pubmed-7160081
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Springer Berlin Heidelberg
record_format MEDLINE/PubMed
spelling pubmed-71600812020-04-23 Minimal ablative margin (MAM) assessment with image fusion: an independent predictor for local tumor progression in hepatocellular carcinoma after stereotactic radiofrequency ablation Laimer, Gregor Schullian, Peter Jaschke, Nikolai Putzer, Daniel Eberle, Gernot Alzaga, Amilcar Odisio, Bruno Bale, Reto Eur Radiol Interventional OBJECTIVES: To assess the minimal ablative margin (MAM) by image fusion of intraprocedural pre- and post-ablation contrast-enhanced CT images and to evaluate if it can predict local tumor progression (LTP) independently. Furthermore, to determine a MAM with which a stereotactic radiofrequency ablation (SRFA) can be determined successful and therefore used as an intraprocedural tool to evaluate treatment success. METHODS: A total of 110 patients (20 women, 90 men; mean age 63.7 ± 10.2) with 176 hepatocellular carcinomas were assessed by retrospective analysis of prospectively collected data. The MAM was determined through image fusion of intraprocedural pre- and post-ablation images using commercially available rigid imaging registration software. LTP was assessed in contrast-enhanced CTs or MR scans at 3–6-month intervals. RESULTS: The MAM was the only significant independent predictor of LTP (p = 0.036). For each millimeter increase of the MAM, a 30% reduction of the relative risk for LTP was found (OR = 0.7, 95% CI 0.5–0.98, p = 0.036). No LTP was detected in lesions with a MAM > 5 mm. The overall LTP rate was 9 of 110 (8.2%) on a patient level and 10 of 173 (5.7%) on a lesion level. The median MAM was 3.4 (1.7–6.9) mm. The mean overall follow-up period was 26.0 ± 10.3 months. CONCLUSIONS: An immediate assessment of the minimal ablative margin (MAM) can be used as an intraprocedural tool to evaluate the treatment success in patients treated with stereotactic RFA. A MAM > 5 mm has to be achieved to consider an ablation as successful. KEY POINTS: • An intraoperatively measured minimal ablative margin (MAM) > 5 mm correlates with complete remission. • MAM is the only significant independent predictor of LTP (OR = 0.7, 95% CI 0.5–0.98, p = 0.036) after stereotactic RFA of hepatocellular carcinoma. • Image fusion using commercially available rigid imaging registration software is possible, even though considerably complex. Therefore, improved (semi-)automatic fusion software is highly desirable. Springer Berlin Heidelberg 2020-01-30 2020 /pmc/articles/PMC7160081/ /pubmed/32002642 http://dx.doi.org/10.1007/s00330-019-06609-7 Text en © The Author(s) 2019 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
spellingShingle Interventional
Laimer, Gregor
Schullian, Peter
Jaschke, Nikolai
Putzer, Daniel
Eberle, Gernot
Alzaga, Amilcar
Odisio, Bruno
Bale, Reto
Minimal ablative margin (MAM) assessment with image fusion: an independent predictor for local tumor progression in hepatocellular carcinoma after stereotactic radiofrequency ablation
title Minimal ablative margin (MAM) assessment with image fusion: an independent predictor for local tumor progression in hepatocellular carcinoma after stereotactic radiofrequency ablation
title_full Minimal ablative margin (MAM) assessment with image fusion: an independent predictor for local tumor progression in hepatocellular carcinoma after stereotactic radiofrequency ablation
title_fullStr Minimal ablative margin (MAM) assessment with image fusion: an independent predictor for local tumor progression in hepatocellular carcinoma after stereotactic radiofrequency ablation
title_full_unstemmed Minimal ablative margin (MAM) assessment with image fusion: an independent predictor for local tumor progression in hepatocellular carcinoma after stereotactic radiofrequency ablation
title_short Minimal ablative margin (MAM) assessment with image fusion: an independent predictor for local tumor progression in hepatocellular carcinoma after stereotactic radiofrequency ablation
title_sort minimal ablative margin (mam) assessment with image fusion: an independent predictor for local tumor progression in hepatocellular carcinoma after stereotactic radiofrequency ablation
topic Interventional
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7160081/
https://www.ncbi.nlm.nih.gov/pubmed/32002642
http://dx.doi.org/10.1007/s00330-019-06609-7
work_keys_str_mv AT laimergregor minimalablativemarginmamassessmentwithimagefusionanindependentpredictorforlocaltumorprogressioninhepatocellularcarcinomaafterstereotacticradiofrequencyablation
AT schullianpeter minimalablativemarginmamassessmentwithimagefusionanindependentpredictorforlocaltumorprogressioninhepatocellularcarcinomaafterstereotacticradiofrequencyablation
AT jaschkenikolai minimalablativemarginmamassessmentwithimagefusionanindependentpredictorforlocaltumorprogressioninhepatocellularcarcinomaafterstereotacticradiofrequencyablation
AT putzerdaniel minimalablativemarginmamassessmentwithimagefusionanindependentpredictorforlocaltumorprogressioninhepatocellularcarcinomaafterstereotacticradiofrequencyablation
AT eberlegernot minimalablativemarginmamassessmentwithimagefusionanindependentpredictorforlocaltumorprogressioninhepatocellularcarcinomaafterstereotacticradiofrequencyablation
AT alzagaamilcar minimalablativemarginmamassessmentwithimagefusionanindependentpredictorforlocaltumorprogressioninhepatocellularcarcinomaafterstereotacticradiofrequencyablation
AT odisiobruno minimalablativemarginmamassessmentwithimagefusionanindependentpredictorforlocaltumorprogressioninhepatocellularcarcinomaafterstereotacticradiofrequencyablation
AT balereto minimalablativemarginmamassessmentwithimagefusionanindependentpredictorforlocaltumorprogressioninhepatocellularcarcinomaafterstereotacticradiofrequencyablation